Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017.
Stecher M, Schommers P, Kollan C, Stoll M, Kuhlendahl F, Stellbrink HJ, Wasmuth JC, Stephan C, Hamacher L, Lehmann C, Boesecke C, Bogner J, Esser S, Fritzsche C, Haberl A, Schürmann D, Degen O, Horst HA, Hoffmann C, Jensen B, Schwarze-Zander C, Platten M, Fätkenheuer G, Schmidt D, Gunsenheimer-Bartmeyer B, Vehreschild JJ; ClinSurv Study Group. Stecher M, et al. Among authors: vehreschild jj. Infection. 2020 Oct;48(5):723-733. doi: 10.1007/s15010-020-01469-6. Epub 2020 Jul 1. Infection. 2020. PMID: 32613529 Free PMC article.
Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials.
Stecher M, Claßen A, Klein F, Lehmann C, Gruell H, Platten M, Wyen C, Behrens G, Fätkenheuer G, Vehreschild JJ. Stecher M, et al. Among authors: vehreschild jj. Clin Infect Dis. 2020 Mar 17;70(7):1406-1417. doi: 10.1093/cid/ciz417. Clin Infect Dis. 2020. PMID: 31102444
Rapid Uptake of Pre-Exposure Prophylaxis After Significant Price Reduction in Germany Highlights Importance of Pre-Exposure Prophylaxis Accessibility.
Mysior P, Tenberken E, Stecher M, Vehreschild JJ, Schafberger A, Perea I, Brillen AL, Bartmeyer B, Esser S, Bremer V, Marcus U, Hoffmann D, Streeck H. Mysior P, et al. Among authors: vehreschild jj. AIDS Res Hum Retroviruses. 2020 Sep;36(9):721-733. doi: 10.1089/AID.2019.0237. Epub 2020 May 11. AIDS Res Hum Retroviruses. 2020. PMID: 32164425
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-20181.
Stecher M, Chaillon A, Stephan C, Knops E, Kohmer N, Lehmann C, Eberle J, Bogner J, Spinner CD, Eis-Hübinger AM, Wasmuth JC, Schäfer G, Behrens G, Mehta SR, Vehreschild JJ, Hoenigl M. Stecher M, et al. Among authors: vehreschild jj. Emerg Infect Dis. 2020 Oct;26(10):2439-2443. doi: 10.3201/eid2610.191506. Emerg Infect Dis. 2020. PMID: 32946725 Free PMC article.
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Jakob CEM, Borgmann S, Duygu F, Behrends U, Hower M, Merle U, Friedrichs A, Tometten L, Hanses F, Jung N, Rieg S, Wille K, Grüner B, Klinker H, Gersbacher-Runge N, Hellwig K, Eberwein L, Dolff S, Rauschning D, von Bergwelt-Baildon M, Lanznaster J, Strauß R, Trauth J, de With K, Ruethrich M, Lueck C, Nattermann J, Tscharntke L, Pilgram L, Fuhrmann S, Classen A, Stecher M, Schons M, Spinner C, Vehreschild JJ. Jakob CEM, et al. Among authors: vehreschild jj. Infection. 2021 Feb;49(1):63-73. doi: 10.1007/s15010-020-01499-0. Epub 2020 Oct 1. Infection. 2021. PMID: 33001409 Free PMC article.
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
Neesgaard B, Mocroft A, Zangerle R, Wit F, Lampe F, Günthard HF, Necsoi C, Law M, Mussini C, Castagna A, Monforte AD, Pradier C, Chkhartisvilli N, Reyes-Uruena J, Vehreschild JJ, Wasmuth JC, Sönnerborg A, Stephan C, Greenberg L, Llibre JM, Volny-Anne A, Peters L, Pelchen-Matthews A, Vannappagari V, Gallant J, Rieger A, Youle M, Braun D, De Wit S, Petoumenos K, Borghi V, Spagnuolo V, Tsertsvadze T, Lundgren J, Ryom L; RESPOND study group. Neesgaard B, et al. Among authors: vehreschild jj. PLoS One. 2020 Dec 31;15(12):e0243625. doi: 10.1371/journal.pone.0243625. eCollection 2020. PLoS One. 2020. PMID: 33382756 Free PMC article. Clinical Trial.
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning.
Jakob CEM, Mahajan UM, Oswald M, Stecher M, Schons M, Mayerle J, Rieg S, Pletz M, Merle U, Wille K, Borgmann S, Spinner CD, Dolff S, Scherer C, Pilgram L, Rüthrich M, Hanses F, Hower M, Strauß R, Massberg S, Er AG, Jung N, Vehreschild JJ, Stubbe H, Tometten L, König R; LEOSS Study group. Jakob CEM, et al. Among authors: vehreschild jj. Infection. 2022 Apr;50(2):359-370. doi: 10.1007/s15010-021-01656-z. Epub 2021 Jul 19. Infection. 2022. PMID: 34279815 Free PMC article.
Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017.
Stecher M, Schommers P, Kollan C, Stoll M, Kuhlendahl F, Stellbrink HJ, Wasmuth JC, Stephan C, Hamacher L, Lehmann C, Boesecke C, Bogner J, Esser S, Fritzsche C, Haberl A, Schürmann D, Degen O, Horst HA, Hoffmann C, Jensen B, Schwarze-Zander C, Platten M, Fätkenheuer G, Schmidt D, Gunsenheimer-Bartmeyer B, Vehreschild JJ; ClinSurv Study Group. Stecher M, et al. Among authors: vehreschild jj. Infection. 2021 Dec;49(6):1365-1366. doi: 10.1007/s15010-021-01655-0. Infection. 2021. PMID: 34346028 Free PMC article. No abstract available.
224 results